During the past decade, Tokyo Kamata Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tokyo Kamata Hospital" are "Nocturia" (2 trials). Many other conditions were trialed in "Tokyo Kamata Hospital" in a lesser frequency.

Most popular intervention types in "Tokyo Kamata Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "A. Desmopressin 10 microgram" (1 trials), "A: Desmopressin 25 µg" (1 trials), "B. Desmopressin 50 µg" (1 trials), "B: Desmopressin 25 microgram" (1 trials) and "C: Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Kamata Hospital" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tokyo Kamata Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tokyo Kamata Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Kamata Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".